Found 7 matching trials
Combination Drug-Therapy for Patients With Untreated Obstructive Sleep Apnea
PHASE2Obstructive sleep apnea (OSA) is common and associated with many adverse he...
Location
Altman Clinical and Translational Research Institute Building
A Clinical Study to Assess Next-day Driving Performance Following Administration of ACT-541468 in Middle-aged and Elderly Subjects
PHASE1A clinical study to assess next-day driving performance following evening a...
Location
Centre for Human Drug Research
Study to Evaluate the Effect of Lemborexant Versus Placebo on Driving Performance in Healthy Adult and Elderly Subjects
PHASE1This is a randomized, double-blind, placebo- and active-controlled, 4-perio...
Location
Maastricht University
A Study to Evaluate Next Day Effects of MK-4305 on Driving Performance (MK-4305-035 AM1)
PHASE1This is a study to evaluate next-day residual effects of MK-4305 on highway...
Location
Merck Sharp & Dohme B.V.
Driving Performance After Middle of the Night Administration of 3.5 mg Zolpidem Tartrate Sublingual Tablet
PHASE1A study in healthy volunteers of the next morning driving performance after...
Location
Maastricht University
Endotype-Targeted Therapy to Rescue OSA Patients Struggling With CPAP Adherence (TOP-CPAP)
PHASE2More than 10% of the US population have obstructive sleep apnea (OSA). Stan...
Location
UC San Diego; Altman Clinical and Translational Research Institute Building
Safety and Efficacy of Ramelteon in Adults With Chronic Insomnia
PHASE3The purpose of the study is to evaluate the safety and efficacy of Ramelteo...
Location
Multiple Locations